Cleared Traditional

K230742 - ACCLARENT AERA Eustachian Tube Dilation System (FDA 510(k) Clearance)

Dec 2023
Decision
271d
Days
Class 2
Risk

K230742 is an FDA 510(k) clearance for the ACCLARENT AERA Eustachian Tube Dilation System. This device is classified as a Eustachian Tube Balloon Dilation Device (Class II - Special Controls, product code PNZ).

Submitted by Acclarent, Inc. (Irvine, US). The FDA issued a Cleared decision on December 13, 2023, 271 days after receiving the submission on March 17, 2023.

This device falls under the Ear, Nose, Throat FDA review panel. Regulated under 21 CFR 874.4180. The Device Is Intended For Use In Dilating The Cartilaginous Portion Of The Eustachian Tube For Treating Persistent Eustachian Tube Dysfunction..

Submission Details

510(k) Number K230742 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 17, 2023
Decision Date December 13, 2023
Days to Decision 271 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary Summary PDF

Device Classification

Product Code PNZ — Eustachian Tube Balloon Dilation Device
Device Class Class II - Special Controls
CFR Regulation 21 CFR 874.4180
Definition The Device Is Intended For Use In Dilating The Cartilaginous Portion Of The Eustachian Tube For Treating Persistent Eustachian Tube Dysfunction.